Recently, frameshift extension mutations in CALR (encoding calreticulin) were identified in myeloproliferative neoplasms [77] and WT1 extension mutants have been described in Wilms kidney tumours [78]. This evidence concerns the gene WT1 and myeloproliferative disorder.